Oxford Cannabinoid Technologies Holdings Management
Management criteria checks 1/4
Oxford Cannabinoid Technologies Holdings' CEO is Clarissa Sowemimo-Coker, appointed in Dec 2022, has a tenure of 1.42 years. total yearly compensation is £215.67K, comprised of 90% salary and 10% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth £9.00K. The average tenure of the management team and the board of directors is 1.4 years and 2.1 years respectively.
Key information
Clarissa Sowemimo-Coker
Chief executive officer
UK£215.7k
Total compensation
| CEO salary percentage | 90.0% |
| CEO tenure | 1.4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 1.4yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Oct 31 2023 | n/a | n/a | -UK£4m |
| Jul 31 2023 | n/a | n/a | -UK£5m |
| Apr 30 2023 | UK£216k | UK£194k | -UK£6m |
| Apr 30 2022 | UK£194k | UK£174k | -UK£5m |
| May 31 2021 | n/a | n/a | -UK£3m |
Compensation vs Market: Clarissa's total compensation ($USD269.45K) is about average for companies of similar size in the UK market ($USD344.28K).
Compensation vs Earnings: Clarissa's compensation has increased whilst the company is unprofitable.
CEO
Clarissa Sowemimo-Coker (43 yo)
1.4yrs
Tenure
UK£215,669
Compensation
Ms. Clarissa Ann Sowemimo-Coker serves as Chief Executive Officer at Oxford Cannabinoid Technologies Holdings Plc since April 12, 2023 and is its Executive Director since February 4, 2021. She was its Comp...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 1.4yrs | UK£215.67k | 0.23% £ 9.0k | |
| Finance Director & Executive Director | 1.6yrs | UK£155.16k | no data | |
| Co-Founder & Non-Executive Director | no data | UK£249.52k | 13.19% £ 517.0k | |
| Chief Scientific Officer | 3.8yrs | no data | no data | |
| General Counsel & Company Secretary | 1.4yrs | no data | 0.030% £ 1.2k | |
| Executive Director & Chief Medical Officer | less than a year | no data | no data |
1.4yrs
Average Tenure
50yo
Average Age
Experienced Management: OCTP's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | UK£215.67k | 0.23% £ 9.0k | |
| Finance Director & Executive Director | 1.6yrs | UK£155.16k | no data | |
| Co-Founder & Non-Executive Director | 3.3yrs | UK£249.52k | 13.19% £ 517.0k | |
| Executive Director & Chief Medical Officer | less than a year | no data | no data | |
| Independent Non-Executive Chair | 3.1yrs | UK£45.00k | 0.060% £ 2.3k | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Senior Independent Non-Executive Director | 3.1yrs | UK£22.92k | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
2.1yrs
Average Tenure
50yo
Average Age
Experienced Board: OCTP's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.